These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7856900)

  • 1. Studies on the safety of chronically administered intrathecal neostigmine methylsulfate in rats and dogs.
    Yaksh TL; Grafe MR; Malkmus S; Rathbun ML; Eisenach JC
    Anesthesiology; 1995 Feb; 82(2):412-27. PubMed ID: 7856900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spinal delivery of sufentanil, alfentanil, and morphine in dogs. Physiologic and toxicologic investigations.
    Sabbe MB; Grafe MR; Mjanger E; Tiseo PJ; Hill HF; Yaksh TL
    Anesthesiology; 1994 Oct; 81(4):899-920. PubMed ID: 7943841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I safety assessment of intrathecal neostigmine methylsulfate in humans.
    Hood DD; Eisenach JC; Tuttle R
    Anesthesiology; 1995 Feb; 82(2):331-43. PubMed ID: 7856891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronically infused intrathecal morphine in dogs.
    Yaksh TL; Horais KA; Tozier NA; Allen JW; Rathbun M; Rossi SS; Sommer C; Meschter C; Richter PJ; Hildebrand KR
    Anesthesiology; 2003 Jul; 99(1):174-87. PubMed ID: 12826858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology and toxicology of chronically infused epidural clonidine.HCl in dogs.
    Yaksh TL; Rathbun M; Jage J; Mirzai T; Grafe M; Hiles RA
    Fundam Appl Toxicol; 1994 Oct; 23(3):319-35. PubMed ID: 7835532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical toxicity screening of intrathecal adenosine in rats and dogs.
    Chiari A; Yaksh TL; Myers RR; Provencher J; Moore L; Lee CS; Eisenach JC
    Anesthesiology; 1999 Sep; 91(3):824-32. PubMed ID: 10485794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicology of baclofen continuously infused into the spinal intrathecal space of the dog.
    Sabbe MB; Grafe MR; Pfeifer BL; Mirzai TH; Yaksh TL
    Neurotoxicology; 1993; 14(4):397-410. PubMed ID: 8164885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the safety of glucose and paraben-containing neostigmine for intrathecal administration.
    Gurun MS; Leinbach R; Moore L; Lee CS; Owen MD; Eisenach JC
    Anesth Analg; 1997 Aug; 85(2):317-23. PubMed ID: 9249107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive effects of spinal cholinesterase inhibition and isobolographic analysis of the interaction with mu and alpha 2 receptor systems.
    Naguib M; Yaksh TL
    Anesthesiology; 1994 Jun; 80(6):1338-48. PubMed ID: 8010479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal ketorolac in dogs and rats.
    Yaksh TL; Horais KA; Tozier N; Rathbun M; Richter P; Rossi S; Grafe M; Tong C; Meschter C; Cline JM; Eisenach J
    Toxicol Sci; 2004 Aug; 80(2):322-34. PubMed ID: 15141096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic action of acute and chronic intraspinally administered opiate and alpha 2-adrenergic agonists in chronic neuropathic pain.
    Levy R; Leiphart J; Dills C
    Stereotact Funct Neurosurg; 1994; 62(1-4):279-89. PubMed ID: 7631082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of continuous lumbar intrathecal infusion of leptin in rats on weight regulation.
    Yaksh TL; Scott B; LeBel CL
    Neuroscience; 2002; 110(4):703-10. PubMed ID: 11934477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical toxicity screening of intrathecal oxytocin in rats and dogs.
    Yaksh TL; Hobo S; Peters C; Osborn KG; Richter PJ; Rossi SS; Grafe MR; Eisenach JC
    Anesthesiology; 2014 Apr; 120(4):951-61. PubMed ID: 24492326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal and systemic action of the alpha 2 receptor agonist dexmedetomidine in dogs. Antinociception and carbon dioxide response.
    Sabbe MB; Penning JP; Ozaki GT; Yaksh TL
    Anesthesiology; 1994 May; 80(5):1057-72. PubMed ID: 7912480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic intrathecal infusion of a partial differential opioid agonist in dogs.
    Horais K; Hruby V; Rossi S; Cizkova D; Meschter C; Dorr R; Yaksh TL
    Toxicol Sci; 2003 Feb; 71(2):263-75. PubMed ID: 12563112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic analysis of ziconotide (SNX-111), an intrathecal N-type calcium channel blocking analgesic, delivered by bolus and infusion in the dog.
    Yaksh TL; de Kater A; Dean R; Best BM; Miljanich GP
    Neuromodulation; 2012; 15(6):508-19; discussion 519. PubMed ID: 22748108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety assessment of encapsulated morphine delivered epidurally in a sustained-release multivesicular liposome preparation in dogs.
    Yaksh TL; Provencher JC; Rathbun ML; Myers RR; Powell H; Richter P; Kohn FR
    Drug Deliv; 2000; 7(1):27-36. PubMed ID: 10895417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiorespiratory and spinal cord blood flow effects of intrathecal neostigmine methylsulfate, clonidine, and their combination in sheep.
    Hood DD; Eisenach JC; Tong C; Tommasi E; Yaksh TL
    Anesthesiology; 1995 Feb; 82(2):428-35. PubMed ID: 7856901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiallodynic effects of intrathecal cholinesterase inhibitors in a rat model of neuropathic pain.
    Hwang JH; Hwang KS; Leem JK; Park PH; Han SM; Lee DM
    Anesthesiology; 1999 Feb; 90(2):492-9. PubMed ID: 9952157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiallodynic effect of intrathecal neostigmine is mediated by spinal nitric oxide in a rat model of diabetic neuropathic pain.
    Chen SR; Khan GM; Pan HL
    Anesthesiology; 2001 Oct; 95(4):1007-12. PubMed ID: 11605898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.